Latacom

Timolol maleate and latanoprost, the active ingredients in Latacom, are a beta‑adrenergic antagonist and a prostaglandin F2α analog presented as eye drops for ocular use. They are indicated for the reduction of intra‑ocular pressure in adults with open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latacom as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers. Latacom is manufactured under EU GMP guidelines and distributed through a secure cold‑chain logistics network to ensure product integrity.

Latacom is used to lower intra‑ocular pressure in glaucoma‑related conditions.

Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers pressure to prevent conversion to glaucoma. Secondary open‑angle glaucoma: helps control pressure when other therapies are insufficient. Normal tension glaucoma: may be considered to achieve target pressure.

The most frequently reported ocular and systemic reactions to Latacom are listed below.

Common Side Effects: - Blurred vision: temporary loss of visual clarity after instillation. - Eye irritation or burning: mild discomfort at the application site. - Redness of the conjunctiva: mild hyperemia. - Increased eyelash growth: longer, thicker lashes. - Dry eye sensation: reduced tear production.

Serious or Rare Side Effects: - Allergic contact dermatitis: swelling, itching, or rash around the eye. - Severe eye pain: may indicate corneal toxicity. - Sudden loss of vision: urgent ophthalmic evaluation required. - Systemic bradycardia or hypotension: due to timolol absorption. - Bronchospasm: especially in patients with asthma.

Before prescribing Latacom, clinicians should consider the following precautions. - Cardiovascular assessment: timolol may cause bradycardia or lower blood pressure. - Respiratory status: avoid in patients with severe asthma or COPD due to beta‑blockade. - History of ocular surgery: monitor intra‑ocular pressure closely after procedures. - Known hypersensitivity: discontinue if allergic reaction occurs. - Pregnancy and lactation: use only if potential benefit justifies risk. - Store at room temperature: keep in original container, protect from light and moisture.

Latacom may interact with other medicines; relevant interactions are grouped by clinical significance.

Major Interactions (Avoid): - Systemic beta‑blockers (e.g., oral propranolol): additive bradycardia and hypotension. - Adrenergic agonists (e.g., epinephrine eye drops): may diminish intra‑ocular pressure reduction. - MAO inhibitors: increased risk of cardiovascular depression with timolol.

Moderate Interactions (Monitor Closely): - Other prostaglandin analogues: potential additive ocular effects. - Topical anesthetics: may increase corneal irritation. - Anticholinergic eye drops: could affect pupil size and pressure dynamics.